• 1
    Ito H. Quality and performance improvement for mental healthcare in Japan. Curr. Opin. Psychiatry 2009; 22: 619622.
  • 2
    Oshima I, Mino Y, Inomata Y. Institutionalization and schizophrenia in Japan: Social environments and negative symptoms: Nationwide survey of in-patients. Br. J. Psychiatry 2003; 183: 5056.
  • 3
    McCabe R, Saidi M, Priebe S. Patient-reported outcomes in schizophrenia. Br. J. Psychiatry 2007; 191 (Suppl 50): S21S28.
  • 4
    Hamann J, Leucht S, Kissling W. Shared decision making in psychiatry. Acta Psychiatr. Scand. 2003; 107: 403409.
  • 5
    Hamann J, Langer B, Winkler V et al. Shared decision making for in-patients with schizophrenia. Acta Psychiatr. Scand. 2006; 114: 265273.
  • 6
    Takamatsu T, Hashimoto T, Taira M, Fukutake M, Maeda K. Scale for measuring self-recoverability in daily life for people with schizophrenia. Psychiatry Clin. Neurosci. 2009; 63: 277282.
  • 7
    Taira M, Hashimoto T, Takamatsu T, Maeda K. Subjective response to neuroleptics: The effect of a questionnaire about neuroleptic side effects. Prog. Neuropsychopharmacol Biol. Psychiatry 2006; 30: 11391142.
  • 8
    Fleischhacker WW, Rabinowitz J, Kemmler G, Eerdekens M, Mehnert A. Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year. Br. J. Psychiatry 2005; 187: 131136.
  • 9
    Russo J, Trujillo CA, Wingerson D et al. The MOS 36-Item Short Form Health Survey: Reliability, validity, and preliminary findings in schizophrenic outpatients. Med. Care 1998; 36: 752756.
  • 10
    Lehman AF, Fischer EP, Postrado L et al. The Schizophrenia Care and Assessment Program Health Questionnaire (SCAP-HQ): An instrument to assess outcomes of schizophrenia care. Schizophr. Bull. 2003; 29: 247256.
  • 11
    Naber D, Moritz S, Lambert M et al. Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs. Schizophr. Res. 2001; 50: 7988.
  • 12
    Kobayashi M, Tomioka N, Fukushima S. Developing of inventory scale of daily activities for sub-acute in-patients (ISDA) and inventory scale for mood and sense of fatigue (SMSF). Jpn. J. Psychiatr. Rehabil. 2006; 10: 1819 (in Japanese).
  • 13
    Dickey B. Outcomes Assessment in Clinical Practice. Lippincott Williams & Wilkins, Baltimore, 1996.
  • 14
    Bartko JJ. On various intraclass correlation reliability coefficients. Psychol. Bull. 1976; 83: 762765.
  • 15
    Organization WH. International Classification of Diseases and Related Health Problems-10th Revision. World Health Organization, Geneva, 2004.
  • 16
    Fayers PM, Machin D. Quality of Life : The Assessment, Analysis and Interpretation of Patient-Reported Outcomes. John Wiley & Sons, Chichester, 2007.
  • 17
    Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum, Hillsdale, 1988.
  • 18
    Overall J, Gorham D. The brief psychiatric rating-scale. Psychol. Rep. 1962; 10: 799812.
  • 19
    Overall JE, Hollister LE, Pichot P. Major psychiatric disorders. A four-dimensional model. Arch. Gen. Psychiatry 1967; 16: 146151.
  • 20
    Samsa G, Edelman D, Rothman ML et al. Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999; 15: 141155.
  • 21
    Nakai H, Yamaguchi N. Kango no tame no seishin igaku [Psychiatry for Nursing]. Igaku Shoin, Tokyo, 2001 (in Japanese).
  • 22
    Tunis SL, Croghan TW, Heilman DK, Johnstone BM, Obenchain RL. Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol. Med. Care 1999; 37: 678691.